Intuitive Surgical
Stock Forecast, Prediction & Price Target
Intuitive Surgical (ISRG) stock Price Target by analysts
Intuitive Surgical (ISRG) stock Price Target by analysts
Average Price Target
$645
Potential upside: 33.70%
Intuitive Surgical price prediction
What is Intuitive Surgical stock analysts` prediction?
Intuitive Surgical stock forecast: Based on 2 Wall Street analysts` predicted price targets for Intuitive Surgical in the last 3 months, the avarage price target is $645, with a high forecast of $NaN. The average price target represents a 33.70% change from the last price of $482.42.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Intuitive Surgical stock Price Target by analysts
Full breakdown of analysts given Intuitive Surgical price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Richard Newitter Truist Financial | 0% 0/4 | 11 months ago | $640 32.66% upside | $526.47 | TheFly | Previous targets (3) |
Patrick Wood Morgan Stanley | 0% 0/1 | 11 months ago | $650 34.73% upside | $541.93 | StreetInsider | Previous targets (0) |
Anthony Petrone Mizuho Securities | 50% 1/2 | about 1 year ago | $550 14.00% upside | $473.73 | StreetInsider | Previous targets (1) |
Shagun Singh RBC Capital | 40% 2/5 | about 1 year ago | $555 15.04% upside | $473.73 | StreetInsider | Previous targets (4) |
Vijay Kumar Evercore ISI | 25% 1/4 | about 1 year ago | $490 1.57% upside | $473.73 | StreetInsider | Previous targets (3) |
Ryan Zimmerman BTIG | 20% 1/5 | about 1 year ago | $535 10.89% upside | $473.73 | StreetInsider | Previous targets (4) |
Rick Wise Stifel Nicolaus | 16.67% 1/6 | about 1 year ago | $525 8.82% upside | $473.73 | StreetInsider | Previous targets (5) |
Richard Newitter Truist Financial | 0% 0/4 | about 1 year ago | $570 18.15% upside | $473.73 | StreetInsider | Previous targets (3) |
David Roman Goldman Sachs | 0% 0/2 | about 1 year ago | $604 25.20% upside | $517.97 | Benzinga | Previous targets (1) |
Adam Maeder Piper Sandler | 0% 0/3 | about 1 year ago | $538 11.52% upside | $473.73 | TheFly | Previous targets (2) |
Larry Biegelsen Wells Fargo | 50% 1/2 | about 1 year ago | $466 -3.40% downside | $487.61 | StreetInsider | Previous targets (1) |
David Rescott Robert W. Baird | 0% 0/2 | about 1 year ago | $565 17.11% upside | $487.61 | StreetInsider | Previous targets (1) |
Ryan Zimmerman BTIG | 20% 1/5 | about 1 year ago | $518 7.37% upside | $484.78 | TheFly | Previous targets (4) |
Shagun Singh RBC Capital | 40% 2/5 | about 1 year ago | $525 8.82% upside | $471.23 | TheFly | Previous targets (4) |
Vijay Kumar Evercore ISI | 25% 1/4 | about 1 year ago | $475 -1.53% downside | $491.27 | TheFly | Previous targets (3) |
Joanne Wuensch Citigroup | 50% 1/2 | about 1 year ago | $560 16.08% upside | $487.42 | TheFly | Previous targets (1) |
Drew Ranieri Morgan Stanley | 50% 1/2 | over 1 year ago | $475 -1.53% downside | $451.61 | TheFly | Previous targets (1) |
Vijay Kumar Evercore ISI | 25% 1/4 | over 1 year ago | $410 -15.01% downside | $416.14 | TheFly | Previous targets (3) |
Rick Wise Stifel Nicolaus | 16.67% 1/6 | over 1 year ago | $475 -1.53% downside | $416.14 | TheFly | Previous targets (5) |
Richard Newitter Truist Financial | 0% 0/4 | over 1 year ago | $520 7.78% upside | $455.01 | StreetInsider | Previous targets (3) |
Adam Maeder Piper Sandler | 0% 0/3 | over 1 year ago | $495 2.60% upside | $416.14 | TheFly | Previous targets (2) |
Richard Newitter Truist Financial | 0% 0/4 | over 1 year ago | $515 6.75% upside | $440.65 | TheFly | Previous targets (3) |
David Roman Goldman Sachs | 0% 0/2 | over 1 year ago | $500 3.64% upside | $398.4 | StreetInsider | Previous targets (1) |
Matthew Taylor Jefferies | 100% 1/1 | over 1 year ago | $375 -22.26% downside | $372.63 | StreetInsider | Previous targets (0) |
Imron Zafar Deutsche Bank | 66.67% 2/3 | over 1 year ago | $390 -19.15% downside | $372.63 | StreetInsider | Previous targets (2) |
Ryan Zimmerman BTIG | 20% 1/5 | over 1 year ago | $421 -12.73% downside | $372.63 | StreetInsider | Previous targets (4) |
David Rescott Robert W. Baird | 0% 0/2 | over 1 year ago | $436 -9.62% downside | $372.63 | StreetInsider | Previous targets (1) |
Adam Maeder Piper Sandler | 0% 0/3 | over 1 year ago | $435 -9.82% downside | $368.17 | StreetInsider | Previous targets (2) |
Rick Wise Stifel Nicolaus | 16.67% 1/6 | over 1 year ago | $430 -10.86% downside | $388.39 | StreetInsider | Previous targets (5) |
Jayson Bedford Raymond James | 50% 1/2 | about 2 years ago | $310 -35.74% downside | $267.07 | Benzinga | Previous targets (1) |
Anthony Petrone Mizuho Securities | 50% 1/2 | about 2 years ago | $320 -33.66% downside | $267.07 | Benzinga | Previous targets (1) |
Shagun Singh RBC Capital | 40% 2/5 | about 2 years ago | $355 -26.41% downside | $267.07 | Benzinga | Previous targets (4) |
Matt Miksic Barclays | 100% 1/1 | over 2 years ago | $314 -34.91% downside | $298.57 | TheFly | Previous targets (0) |
Unknown Morgan Stanley | N/A | almost 3 years ago | $290 -39.88% downside | $270.57 | Benzinga | N/A |
Unknown Argus Research | N/A | almost 3 years ago | $320 -33.66% downside | $262.37 | Benzinga | N/A |
Unknown Truist Financial | N/A | almost 3 years ago | $310 -35.74% downside | $258.17 | Benzinga | N/A |
Unknown Wells Fargo | N/A | almost 3 years ago | $305 -36.77% downside | $270.99 | Benzinga | N/A |
Unknown BTIG | N/A | almost 3 years ago | $316 -34.49% downside | $269.45 | Benzinga | N/A |
Unknown J.P. Morgan | N/A | almost 3 years ago | $280 -41.95% downside | $266.38 | Benzinga | N/A |
Rick Wise Stifel Nicolaus | 16.67% 1/6 | about 3 years ago | $260 -46.10% downside | $214.78 | TheFly | Previous targets (5) |
Shagun Singh RBC Capital | 40% 2/5 | over 3 years ago | $285 -40.92% downside | $237.71 | Pulse 2.0 | Previous targets (4) |
Unknown Truist Financial | N/A | over 3 years ago | $255 -47.14% downside | $216.67 | Benzinga | N/A |
Rick Wise Stifel Nicolaus | 16.67% 1/6 | over 3 years ago | $250 -48.17% downside | $224.75 | TheFly | Previous targets (5) |
Unknown BTIG | N/A | over 3 years ago | $247 -48.79% downside | $212.93 | Benzinga | N/A |
Unknown Stifel Nicolaus | N/A | over 3 years ago | $270 -44.03% downside | $212.79 | Benzinga | N/A |
Unknown Truist Financial | N/A | over 3 years ago | $270 -44.03% downside | $202.8 | Benzinga | N/A |
Imron Zafar Deutsche Bank | 66.67% 2/3 | over 3 years ago | $225 -53.36% downside | $202.59 | Pulse 2.0 | Previous targets (2) |
Lawrence Keusch Raymond James | 100% 1/1 | over 3 years ago | $330 -31.59% downside | $244.52 | Pulse 2.0 | Previous targets (0) |
Unknown Morgan Stanley | N/A | over 3 years ago | $300 -37.81% downside | $257.29 | Benzinga | N/A |
Unknown Piper Sandler | N/A | over 3 years ago | $316 -34.49% downside | $294.57 | Benzinga | N/A |
Intuitive Surgical Financial Estimates
Intuitive Surgical Revenue Estimates
Intuitive Surgical EBITDA Estimates
Intuitive Surgical Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $5.71B N/A | $6.22B 8.96% | $7.12B 14.49% | Avg: $9.32B Low: $9.22B High: $9.55B avg. 30.89% | Avg: $10.71B Low: $10.48B High: $10.95B avg. 14.88% | Avg: $12.12B Low: $11.86B High: $12.40B avg. 13.21% | Avg: $13.76B Low: $13.46B High: $14.07B avg. 13.45% |
Net Income
% change YoY
| $1.70B N/A | $1.32B -22.42% | $1.79B 35.97% | Avg: $2.27B Low: $2.04B High: $2.70B avg. 26.47% | Avg: $2.66B Low: $2.59B High: $2.85B avg. 17.40% | Avg: $3.52B Low: $3.42B High: $3.62B avg. 32.05% | Avg: $4.11B Low: $3.99B High: $4.23B avg. 16.60% |
EBITDA
% change YoY
| $1.82B N/A | $1.57B -13.39% | $2.18B 38.77% | Avg: $2.66B Low: $2.63B High: $2.72B avg. 21.63% | Avg: $3.05B Low: $2.99B High: $3.12B avg. 14.88% | Avg: $3.46B Low: $3.38B High: $3.54B avg. 13.21% | Avg: $3.92B Low: $3.84B High: $4.01B avg. 13.45% |
EPS
% change YoY
| $4.79 N/A | $3.72 -22.33% | $5.12 37.63% | Avg: $6.34 Low: $5.72 High: $7.57 avg. 23.74% | Avg: $7.57 Low: $7.25 High: $8 avg. 19.52% | Avg: $9.86 Low: $9.59 High: $10.15 avg. 30.27% | Avg: $11.5 Low: $11.18 High: $11.84 avg. 16.60% |
Operating Expenses
% change YoY
| $2.13B N/A | $2.61B 22.52% | $2.96B 13.12% | Avg: $2.52B Low: $2.49B High: $2.58B avg. -14.74% | Avg: $2.90B Low: $2.83B High: $2.96B avg. 14.88% | Avg: $3.28B Low: $3.21B High: $3.35B avg. 13.21% | Avg: $3.72B Low: $3.64B High: $3.81B avg. 13.45% |
FAQ
What is Intuitive Surgical stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 23.13% in 2025-2028.
We have gathered data from 17 analysts. Their low estimate is 2.04B, average is 2.27B and high is 2.70B.
What is Intuitive Surgical stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 18.11% in 2025-2028.
We have gathered data from 22 analysts. Their low revenue estimate is $9.22B, average is $9.32B and high is $9.55B.
What is Intuitive Surgical stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 22.53% in 2025-2028.
We have gathered data from 17 analysts. Their low earnings per share estimate is $5.72, average is $6.34 and high is $7.57.
What is the best performing analyst?
In the last twelve months 2 analysts have been covering Intuitive Surgical stock. The most successful analyst is Richard Newitter.